AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK's proprietary AS01E adjuvant.

Shifting”, “Trojan Horse”, Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in ...

Arsenal, Liverpool and Manchester United are among the eights clubs that provided witness evidence on behalf of the Premier ...

A MAJOR warning has been issued to Irish parents to “trust your instincts” over a deadly virus that can be “easily mistaken” ...

It's called Respiratory Virus Dashboard, replacing the old COVID-19 dashboard. This new tool allows users to explore data for ...

In September, Quebec launched an RSV vaccination campaign for Quebecers who are at least 60 years old and living in long-term ...

Over the weekend, the World Health Organization (WHO) confirmed it began a Jynneos vaccination campaign in the Democratic ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and ...

Autumn is here, and that means cooler weather and also the start of flu season. We know the best way to prevent influenza is ...